Dados B3 › HAGA4 × CSNA3
HAGA4 × CSNA3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | HAGA4 | CSNA3 | year |
|---|---|---|---|
| ROE | — | -15.9% | no year where both have it |
| ROIC | — | 6.2%! | no year where both have it |
| ROA | 3.2% | -1.5% | 2025 |
| Gross margin | 23.1% | 27.7% | 2025 |
| EBIT margin | -3.4% | 10.8% | 2025 |
| Net margin | 7.5% | -3.4% | 2025 |
| Net debt/EBITDA | — | 4.22x | no year where both have it |
| Current ratio | 2.60x | 1.08x | 2025 |
| Revenue growth (1y) | -3.6% | 2.5% | 2025 |
| Revenue growth (5y CAGR) | -0.9% | 8.3% | 2025 |
| Piotroski F-Score | 3/9! | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | HAGA4 | CSNA3 | year |
|---|---|---|---|
| P/E | 2.12x | -4.72x | 2022 × 2025 |
| P/B | — | 0.73x | 2022 × 2025 |
| EV/EBITDA | — | 5.28x | 2022 × 2025 |
| FCF yield | — | -73.1% | 2022 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:51 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:51 UTC. If this does not match /saude, you are reading a cached copy.